These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 34016428)
1. Identifying susceptibility genes for primary ovarian insufficiency on the high-risk genetic background of a fragile X premutation. Trevino CE; Rounds JC; Charen K; Shubeck L; Hipp HS; Spencer JB; Johnston HR; Cutler DJ; Zwick ME; Epstein MP; Murray A; Macpherson JN; Mila M; Rodriguez-Revenga L; Berry-Kravis E; Hall DA; Leehey MA; Liu Y; Welt C; Warren ST; Sherman SL; Jin P; Allen EG Fertil Steril; 2021 Sep; 116(3):843-854. PubMed ID: 34016428 [TBL] [Abstract][Full Text] [Related]
2. Presence of inclusions positive for polyglycine containing protein, FMRpolyG, indicates that repeat-associated non-AUG translation plays a role in fragile X-associated primary ovarian insufficiency. Buijsen RA; Visser JA; Kramer P; Severijnen EA; Gearing M; Charlet-Berguerand N; Sherman SL; Berman RF; Willemsen R; Hukema RK Hum Reprod; 2016 Jan; 31(1):158-68. PubMed ID: 26537920 [TBL] [Abstract][Full Text] [Related]
3. Fragile x-associated premature ovarian failure in a large Turkish cohort: Findings of Hacettepe Fragile X Registry. Utine GE; Şimşek-Kiper PÖ; Akgün-Doğan Ö; Ürel-Demir G; Alanay Y; Aktaş D; Boduroğlu K; Tunçbilek E; Alikaşifoğlu M Eur J Obstet Gynecol Reprod Biol; 2018 Feb; 221():76-80. PubMed ID: 29275276 [TBL] [Abstract][Full Text] [Related]
4. Approaches to identify genetic variants that influence the risk for onset of fragile X-associated primary ovarian insufficiency (FXPOI): a preliminary study. Allen EG; Grus WE; Narayan S; Espinel W; Sherman SL Front Genet; 2014; 5():260. PubMed ID: 25147555 [TBL] [Abstract][Full Text] [Related]
5. An explanation of the mechanisms underlying fragile X-associated premature ovarian insufficiency. Rose BI; Brown SE J Assist Reprod Genet; 2020 Jun; 37(6):1313-1322. PubMed ID: 32377997 [TBL] [Abstract][Full Text] [Related]
7. Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency. Alvarez-Mora MI; Rodriguez-Revenga L; Madrigal I; Garcia-Garcia F; Duran M; Dopazo J; Estivill X; Milà M Gene; 2015 Oct; 571(1):52-7. PubMed ID: 26095811 [TBL] [Abstract][Full Text] [Related]
8. Curvilinear association of CGG repeats and age at menopause in women with FMR1 premutation expansions. Mailick MR; Hong J; Greenberg J; Smith L; Sherman S Am J Med Genet B Neuropsychiatr Genet; 2014 Dec; 165B(8):705-11. PubMed ID: 25346430 [TBL] [Abstract][Full Text] [Related]
9. The diagnostic experience of women with fragile X-associated primary ovarian insufficiency (FXPOI). Poteet B; Ali N; Bellcross C; Sherman SL; Espinel W; Hipp H; Allen EG J Assist Reprod Genet; 2023 Jan; 40(1):179-190. PubMed ID: 36447079 [TBL] [Abstract][Full Text] [Related]
10. Predictors and risk model development for menopausal age in fragile X premutation carriers. Spath MA; Feuth TB; Smits AP; Yntema HG; Braat DD; Thomas CM; van Kessel AG; Sherman SL; Allen EG Genet Med; 2011 Jul; 13(7):643-50. PubMed ID: 21597380 [TBL] [Abstract][Full Text] [Related]
11. Fragile X premutation in women: recognizing the health challenges beyond primary ovarian insufficiency. Hoyos LR; Thakur M J Assist Reprod Genet; 2017 Mar; 34(3):315-323. PubMed ID: 27995424 [TBL] [Abstract][Full Text] [Related]
12. Granulosa cell and oocyte mitochondrial abnormalities in a mouse model of fragile X primary ovarian insufficiency. Conca Dioguardi C; Uslu B; Haynes M; Kurus M; Gul M; Miao DQ; De Santis L; Ferrari M; Bellone S; Santin A; Giulivi C; Hoffman G; Usdin K; Johnson J Mol Hum Reprod; 2016 Jun; 22(6):384-96. PubMed ID: 26965313 [TBL] [Abstract][Full Text] [Related]
13. Women who carry a fragile X premutation are biologically older than noncarriers as measured by telomere length. Albizua I; Rambo-Martin BL; Allen EG; He W; Amin AS; Sherman SL Am J Med Genet A; 2017 Nov; 173(11):2985-2994. PubMed ID: 28941155 [TBL] [Abstract][Full Text] [Related]
15. FMR1 and the continuum of primary ovarian insufficiency. Sullivan SD; Welt C; Sherman S Semin Reprod Med; 2011 Jul; 29(4):299-307. PubMed ID: 21969264 [TBL] [Abstract][Full Text] [Related]
16. Reproductive and gynecologic care of women with fragile X primary ovarian insufficiency (FXPOI). Hipp HS; Charen KH; Spencer JB; Allen EG; Sherman SL Menopause; 2016 Sep; 23(9):993-9. PubMed ID: 27552334 [TBL] [Abstract][Full Text] [Related]
17. The first case described: monozygotic twin sisters with the fragile X premutation but with a different phenotype for premature ovarian failure. Johnston-MacAnanny EB; Koty P; Pettenati M; Brady M; Yalcinkaya TM; Schmidt DW Fertil Steril; 2011 Jun; 95(7):2431.e13-5. PubMed ID: 21300345 [TBL] [Abstract][Full Text] [Related]
18. Association analysis of FMR1 genetic variants and primary ovarian insufficiency in South Indian women with a novel approach of CGG repeats classification. Komaravalli PL; Rani S V; Dalal A; Jahan P Eur J Med Genet; 2020 Dec; 63(12):104081. PubMed ID: 33039683 [TBL] [Abstract][Full Text] [Related]
19. The significance of fragile X mental retardation gene 1 CGG repeat sizes in the normal and intermediate range in women with primary ovarian insufficiency. Voorhuis M; Onland-Moret NC; Janse F; Ploos van Amstel HK; Goverde AJ; Lambalk CB; Laven JS; van der Schouw YT; Broekmans FJ; Fauser BC; Hum Reprod; 2014 Jul; 29(7):1585-93. PubMed ID: 24812319 [TBL] [Abstract][Full Text] [Related]